AGA Family of Websites:
AGA Journals
AGA Journals
AGA University
AGA University
AGA University
AGA Research Foundation
AGA University
AGA Community
AGA University
AGA Job Board
October 16, 2019

AGA addresses need for APP education surrounding IBD and pharmacology

New on-demand modules offer valuable insight and CE credits.
Share on facebook
Share on twitter
Share on linkedin
Share on email

In today’s complex health care environment, it is critical that all members of the multidisciplinary team be well versed in the diagnosis, treatment and evaluation of inflammatory bowel disease (IBD). So too does the need for specialized education surrounding complex topics in IBD.

Advanced Practice Provider Pharmacology: IBD — a new on-demand course from AGA University — provides all clinicians with easy-to-digest information on the pharmacological management of IBD. After completing five self-paced modules, participants will be eligible to receive 2 AMA PRA Category 1 Credits™ or 2 pharmacology credit hours through AANP, and will be able to:

  • Gain a deeper understanding of IBD epidemiology and pathophysiology.
  • Identify the use cases for several types of aminosalicylates based on indications, safety and efficacy profiles, and adverse effects.
  • Summarize the mechanism of action, dosing, and pharmacokinetics of four FDA-approved biologic therapies.
  • Analyze population considerations, therapy-related testing, and health maintenance concerns for the use of several immunomodulator medications.

Gain practical pearls of wisdom that will make you invaluable to the IBD patient care team — access the Advanced Practice Provider Pharmacology: IBD course today!

Complimentary access to this program is made possible by support from Gilead Sciences, Inc. and Takeda Pharmaceuticals U.S.A., Inc.

Your hub for GI education is
AGA University
Discussion Icon

Discuss this news

Share this article in the AGA Community, your member-only platform for sharing your thoughts and ideas with your colleagues.

Not a member? Join AGA.

By using this site, you agree to our updated Privacy Policy.